Nishimoto T - Search Results

1

IGFBP-5 Promotes Fibrosis Independently of Its Translocation to the Nucleus and Its Interaction with Nucleolin and IGF.

Su Y, Nishimoto T, Feghali-Bostwick C. Su Y, et al. Among authors: nishimoto t. PLoS One. 2015 Jun 23;10(6):e0130546. doi: 10.1371/journal.pone.0130546. eCollection 2015. PLoS One. 2015. PMID: 26103640 Free PMC article.

2

An endostatin-derived peptide orally exerts anti-fibrotic activity in a murine pulmonary fibrosis model.

Nishimoto T, Mlakar L, Takihara T, Feghali-Bostwick C. Nishimoto T, et al. Int Immunopharmacol. 2015 Oct;28(2):1102-5. doi: 10.1016/j.intimp.2015.07.039. Epub 2015 Aug 24. Int Immunopharmacol. 2015. PMID: 26315492 Free PMC article.

3

Optimization of a murine and human tissue model to recapitulate dermal and pulmonary features of systemic sclerosis.

Watanabe T, Nishimoto T, Mlakar L, Heywood J, Malaab M, Hoffman S, Feghali-Bostwick C. Watanabe T, et al. Among authors: nishimoto t. PLoS One. 2017 Jun 26;12(6):e0179917. doi: 10.1371/journal.pone.0179917. eCollection 2017. PLoS One. 2017. PMID: 28651005 Free PMC article.

4

Insulin-like growth factor binding protein-4 exerts antifibrotic activity by reducing levels of connective tissue growth factor and the C-X-C chemokine receptor 4.

Su Y, Nishimoto T, Hoffman S, Nguyen XX, Pilewski JM, Feghali-Bostwick C. Su Y, et al. Among authors: nishimoto t. FASEB Bioadv. 2019 Mar;1(3):167-179. doi: 10.1096/fba.2018-00015. Epub 2018 Nov 14. FASEB Bioadv. 2019. PMID: 31482149 Free PMC article.

5

Lysyl oxidase directly contributes to extracellular matrix production and fibrosis in systemic sclerosis.

Nguyen XX, Nishimoto T, Takihara T, Mlakar L, Bradshaw AD, Feghali-Bostwick C. Nguyen XX, et al. Among authors: nishimoto t. Am J Physiol Lung Cell Mol Physiol. 2021 Jan 1;320(1):L29-L40. doi: 10.1152/ajplung.00173.2020. Epub 2020 Oct 7. Am J Physiol Lung Cell Mol Physiol. 2021. PMID: 33026236 Free PMC article.

6

E4 engages uPAR and enolase-1 and activates urokinase to exert antifibrotic effects.

Sharma S, Watanabe T, Nishimoto T, Takihara T, Mlakar L, Nguyen XX, Sanderson M, Su Y, Chambers RA, Feghali-Bostwick C. Sharma S, et al. Among authors: nishimoto t. JCI Insight. 2021 Dec 22;6(24):e144935. doi: 10.1172/jci.insight.144935. JCI Insight. 2021. PMID: 34935642 Free PMC article.

7

A unique thymus-derived regulatory T cell subset associated with systemic lupus erythematosus.

Hanaoka H, Nishimoto T, Okazaki Y, Takeuchi T, Kuwana M. Hanaoka H, et al. Among authors: nishimoto t. Arthritis Res Ther. 2020 Apr 21;22(1):88. doi: 10.1186/s13075-020-02183-2. Arthritis Res Ther. 2020. PMID: 32317002 Free PMC article.

8

CD4+CD25+Foxp3+ regulatory T cells in the pathophysiology of immune thrombocytopenia.

Nishimoto T, Kuwana M. Nishimoto T, et al. Semin Hematol. 2013 Jan;50 Suppl 1:S43-9. doi: 10.1053/j.seminhematol.2013.03.018. Semin Hematol. 2013. PMID: 23664516 Free article. Review.

9

Induction of immune tolerance to platelet antigen by short-term thrombopoietin treatment in a mouse model of immune thrombocytopenia.

Nishimoto T, Numajiri M, Nakazaki H, Okazaki Y, Kuwana M. Nishimoto T, et al. Int J Hematol. 2014 Oct;100(4):341-4. doi: 10.1007/s12185-014-1661-4. Epub 2014 Sep 12. Int J Hematol. 2014. PMID: 25212676

10

Critical role of CD4(+)CD25(+) regulatory T cells in preventing murine autoantibody-mediated thrombocytopenia.

Nishimoto T, Satoh T, Takeuchi T, Ikeda Y, Kuwana M. Nishimoto T, et al. Exp Hematol. 2012 Apr;40(4):279-89. doi: 10.1016/j.exphem.2012.01.001. Epub 2012 Jan 10. Exp Hematol. 2012. PMID: 22240606 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

501 results

Search Page

Filters